N-Nitroso-N-ethylurea
SIGMA/N3385 - ISOPAC®
Synonym: ENU; N-
CAS Number: 759-73-9
Empirical Formula (Hill Notation): C3H7N3O2
Molecular Weight: 117.11
EC Number: 212-072-2
MDL Number: MFCD00053635
Linear Formula: C3H7N3O2
Product Type: Chemical
| form | powder |
| InChI | 1S/C3H7N3O2/c1-2-6(5-8)3( |
| InChI key | FUSGACRLAFQQRL-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CCN(N=O)C(N)=O |
| storage temp. | −20°C |
| Application: | N-Nitroso-N-ethylurea has been used as a mutation-inducing agent. |
| Biochem/physiol Actions: | DNA alkylating agent that is carcinogenic in many animal species. Induces benign and malignant tumors of numerous types, including the nervous tissue, stomach, esophagus, pancreas, respiratory tract, intestine, lymphoreticular tissues, skin, and kidney. |
| Disclaimer: | Injecting any compatible solvent permits preparation of any desired strength solution without exposure. |
| Legal Information: | Isopac is a registered trademark of Merck KGaA, Darmstadt, Germany |
| Packaging: | 1 g in serum bottle |
| Packaging: | Packaged in a 100 mL serum bottle with silicon/PTFE septum and aluminum tear seal. 1 vial contains 1 g of material calculated on anhydrous basis. |
| Preparation Note: | Dissolving the contents in 100 mL of solvent yields a 1% solution. |
| Symbol | ![]() GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H301 - H312 + H332 - H350 - H360 |
| Precautionary statements | P201 - P202 - P280 - P301 + P310 - P302 + P352 + P312 - P304 + P340 + P312 |
| Hazard Codes | T |
| Risk Statements | 45-46-61-20/21/22 |
| Safety Statements | 53-22-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352102 |



